deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 1-arm NCT04632433

Neoadjuvant Plus Adjuvant Treatment With Cemiplimab in Cutaneaous Squamous Cell Carcinoma

A Phase II, Single Arm Study Investigating Neoadjuvant Plus Adjuvant Treatment With Cemiplimab in High Risk, Surgically Resectable, Stage III Cutaneaous Squamous Cell Carcinoma

Sponsor: Fondazione Melanoma Onlus

Conditions Cutaneous Squamous Cell Carcinoma
Interventions Cemiplimab
Updated 11 times since 2020 Last updated: Mar 11, 2025 Started: Feb 10, 2021 Primary completion: Feb 6, 2023 Completion: Feb 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cutaneous Squamous Cell Carcinoma, this trial is ongoing. The trial is conducted by Fondazione Melanoma Onlus and has accumulated 11 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotNot Yet Recruiting~Jan 2021 – ~May 2021 · 4 months · monthly snapshotNot Yet Recruiting~May 2021 – ~Sep 2022 · 16 months · monthly snapshotRecruiting~Sep 2022 – ~Mar 2023 · 6 months · monthly snapshotRecruiting~Mar 2023 – ~Mar 2024 · 12 months · monthly snapshotActive Not Recruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotActive Not Recruiting~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshotActive Not Recruiting~Apr 2025 – ~Jun 2025 · 2 months · monthly snapshotActive Not Recruiting~Jun 2025 – ~Sep 2025 · 3 months · monthly snapshotActive Not Recruiting~Sep 2025 – present · 10 months · monthly snapshotActive Not Recruiting

Change History

11 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting PHASE2

  2. Jun 2025 — Sep 2025 [monthly]

    Active Not Recruiting PHASE2

  3. Apr 2025 — Jun 2025 [monthly]

    Active Not Recruiting PHASE2

  4. Sep 2024 — Apr 2025 [monthly]

    Active Not Recruiting PHASE2

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

▶ Show 6 earlier versions

  1. Mar 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

  2. Mar 2023 — Mar 2024 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  3. Sep 2022 — Mar 2023 [monthly]

    Recruiting PHASE2

  4. May 2021 — Sep 2022 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  5. Jan 2021 — May 2021 [monthly]

    Not Yet Recruiting PHASE2

  6. Dec 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fondazione Melanoma Onlus
Data source: Fondazione Melanoma Onlus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations